A detailed history of Operose Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Operose Advisors LLC holds 635 shares of EW stock, worth $47,866. This represents 0.01% of its overall portfolio holdings.

Number of Shares
635
Previous 635 -0.0%
Holding current value
$47,866
Previous $58,000 29.31%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$72.54 - $95.56 $32,715 - $43,097
-451 Reduced 41.53%
635 $60,000
Q4 2023

Feb 12, 2024

BUY
$61.71 - $77.76 $27,831 - $35,069
451 Added 71.02%
1,086 $82,000
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $31,314 - $42,207
452 Added 246.99%
635 $43,000
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $19,465 - $23,914
183 New
183 $24,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.